Concepedia

Mark Dysinger

MD

5

Publications

113

Citations

5

H-Index

2012

Active since

Affiliations

Pfizer (United States)(Current)

Alexion Pharmaceuticals (United States)

Mark Dysinger is an author at Pfizer (United States) specializing in engineering, medicine, and immunology.

Top concepts

EngineeringMedicineImmunologyBioanalysisOmicsDesignPathologyBiomarkersProteomicsData Science

Publications per year

2012–2018

5

Publications

5

Quantitative analysis of four protein biomarkers: An automated microfluidic cartridge-based method and its comparison to colorimetric ELISA

Mark Dysinger, Greg Marusov, Stephanie Fraser · Journal of Immunological Methods · 2017 · 40 citations

Biomarker (Medicine), Engineering, Protein Biomarkers +14

Practical quantitative and kinetic applications of bio-layer interferometry for toxicokinetic analysis of a monoclonal antibody therapeutic

Mark Dysinger, Lindsay E. King · Journal of Immunological Methods · 2012 · 23 citations

Engineering, Practical Quantitative, Bioanalysis +12

Prandial Ghrelin Attenuation Provides Evidence That Des-Acyl Ghrelin May Be An Artifact of Sample Handling in Human Plasma

Matthew Blatnik, Catherine Soderstrom, Mark Dysinger et al. · Bioanalysis · 2012 · 21 citations

A Multi-site In-depth Evaluation of the Quanterix Simoa from a User’s Perspective

Allison G. Chunyk, Alison Joyce, Saloumeh K Fischer et al. · The AAPS Journal · 2017 · 18 citations

Multi-site In-depth Evaluation, Engineering, Quanterix Simoa +5

A Gyrolab Assay for the Quantitation of Free Complement Protein C5a in Human Plasma

Mark Dysinger, Mark Ma · The AAPS Journal · 2018 · 11 citations

Rows per page

1–5 of 5